Algae-Based Microrobot Drug Delivery via Flagellar Propulsion

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current microrobots face limitations in achieving active propulsion and drug delivery in various body locations due to issues with natural fuels, accessibility, and toxicity, restricting their application to specific areas like the gastrointestinal tract and lungs.

Innovation Solution

A bioinspired microrobot platform using nanoparticle-modified algae, such as Chlamydomonas reinhardtii, with therapeutic agent-loaded membrane-coated polymeric nanoparticles, which utilizes the natural swimming behavior of algae for active drug delivery, providing prolonged retention and locomotion in the GI tract and lungs.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Strength

If rigid metallic or polymeric microrobots are used, then structural strength is improved, but biocompatibility and tissue accessibility deteriorate

Engineering Contradiction:
Improvestructural strengthVSAvoidbiocompatibility
Core Design Contradiction:
StrengthVSObject-affected harmful factors

Solution Approach 1:

The patent employs biohybrid composite microrobots combining dead Chlamydomonas reinhardtii algae cells ( providing biocompatibility and propulsion) with magnetic nanoparticles (providing actuation capability). This composite structure resolves the contradiction by integrating materials with complementary properties: the biological algae component ensures biocompatibility while the magnetic component enables controlled actuation without requiring toxic fuels

Inventive Principle:
Principle #40Composite materials

2Object-affected harmful factors

If biodegradable zinc or magnesium-based microrobots are used for GI tract delivery, then biocompatibility is improved, but application scope to other body locations deteriorates

Engineering Contradiction:
ImprovebiocompatibilityVSAvoidapplication scope
Core Design Contradiction:
Object-affected harmful factorsVSAdaptability or versatility

Solution Approach 1:

The patent changes the material parameters by using magnetically actuated algae-based microrobots instead of biodegradable metal microrobots. This parameter change enables the system to operate in multiple body locations (lungs, GI tract, blood vessels) rather than being restricted to the GI tract, while maintaining biocompatibility through the biological algae component and magnetic nanoparticle coating

Inventive Principle:
Principle #35Parameter changes

3Length of stationary object

If magnetically powered microrobots are used for deep tissue penetration, then accessibility to deep tissues is improved, but control precision and navigation capability deteriorate

Engineering Contradiction:
Improvepenetration depthVSAvoidnavigation precision
Core Design Contradiction:
Length of stationary objectVSManufacturing precision

Solution Approach 1:

The patent introduces an external magnetic field as an intermediary for actuation and navigation. The magnetic nanoparticles embedded in the algae microrobots respond to externally applied magnetic fields, enabling deep tissue penetration and precise navigation without requiring onboard power sources or complex control mechanisms. The magnetic field serves as a non-invasive mediator that can penetrate deep into tissues while maintaining precise spatial control

Inventive Principle:
Principle #24Intermediary (Mediator)

4Quantity of substance

If synthetic cargo-loaded microrobots are used, then drug delivery capacity is improved, but immune clearance and biological compatibility deteriorate

Engineering Contradiction:
Improvedrug loading capacityVSAvoidimmune clearance
Core Design Contradiction:
Quantity of substanceVSObject-affected harmful factors

Solution Approach 1:

The patent employs the algae's natural flagellar propulsion as a self-service mechanism that eliminates the need for synthetic power sources and complex onboard systems. The biological propulsion mechanism reduces immune recognition compared to synthetic microrobots, while the algae cell wall and membrane provide natural biocompatibility. The magnetic nanoparticle coating further enhances biological compatibility while enabling external actuation

Inventive Principle:
Principle #25Self-service

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The algae-based microrobot platform enables efficient and prolonged drug delivery, with enhanced retention and locomotion in target areas, effectively treating infections and diseases by maintaining motility and evading macrophage phagocytosis, thereby improving treatment outcomes.

Implementation Method 1

They can be facilely cultured and offer self-propulsion based on flagella beating (≥110 m s−1)

Methodology Applied
Scientific EffectFlagella beating:

Implementation Method 2

Neutrophil membrane-coated NPs are used because of their unique cell-mimicking properties, including shielding payloads from biological environments, reducing immune clearance

Methodology Applied
Scientific EffectMembrane coating: Coatings

Implementation Method 3

Magnetococcus marinus magneto-aerotactic bacteria, which swim along local magnetic fields and toward low oxygen concentrations

Methodology Applied
Scientific EffectMagnetic field guidance: Magnetic Field

Data Source

PatentUS20240316211A1Algae-based microrobot for drug delivery
Publication Date: 2024.09.26 RGT UNIV OF CALIFORNIA
  • US20240316211A1 patent drawing
  • US20240316211A1 patent drawing
  • US20240316211A1 patent drawing

AI summary

Microalgae combined with antibiotic-loaded neutrophil membrane-coated polymeric nanoparticles provide a hybrid microrobot having robust locomotion in the lungs in vivo toward effective treatment of pulmonary and gastrointestinal tract infections. The algae-nanoparticle hybrid microrobots are provided in methods of treatment of disease or conditions by administration for active in vivo delivery of therapeutics to the lungs or gastrointestinal tract. The microrobot system can be applied to treat a wide range of diseases, including viral pneumonia.